Agnieszka Graczyk-Jarzynka

8PUBLICATIONS
46CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 04, 2026
The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

|Mar 31, 2025
Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Joanna Domagala, Tomasz M Grzywa, Iwona Baranowska

|Dec 10, 2021
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.

Kuba Retecki, Milena Seweryn, Agnieszka Graczyk-Jarzynka

|Dec 02, 2021
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Marta Klopotowska, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka

|Oct 09, 2021
Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies.

Maciej Szydłowski, Filip Garbicz, Ewa Jabłońska

|Jul 30, 2020
The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies.

Andriy Zhylko, Magdalena Winiarska, Agnieszka Graczyk-Jarzynka

Pageof 2

Frequent Collaborators

4 joint publications

Malgorzata Bajor

2 joint publications

Radoslaw Zagozdzon

2 joint publications

Malgorzata Firczuk

2 joint publications

Katsiaryna Marhelava